"CrofootMD is a unique private medical practice which focuses on serving the needs of Houston’s members and friends of the LGBTQ community with special attention to HIV/AIDS, Hepatitis, and other infectious diseases."

During the past decade, Gordon E. Crofoot, MD, PA conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 29 clinical trials were completed, i.e. on average, 181.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gordon E. Crofoot, MD, PA" #1 sponsor was "Gilead Sciences" with 33 trials, followed by "Sangamo Therapeutics" with 2 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Medical College of Wisconsin" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gordon E. Crofoot, MD, PA" #1 collaborator was "Gordon Crofoot MD PA" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "M.D. Anderson Cancer Center" with 1 trials as a collaborator, "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator and "University of Chicago" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gordon E. Crofoot, MD, PA" are "HIV Infections" (16 trials), "HIV-1 Infection" (12 trials), "HIV" (10 trials), "Acquired Immunodeficiency Syndrome" (7 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "Gordon E. Crofoot, MD, PA" in a lesser frequency.

Most popular intervention types in "Gordon E. Crofoot, MD, PA" are "Drug" (34 trials), "Genetic" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (9 trials), "FTC/TDF" (8 trials), "B/F/TAF" (6 trials), "Stribild" (6 trials) and "COBI" (5 trials). Other intervention names were less common.

The vast majority of trials in "Gordon E. Crofoot, MD, PA" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gordon E. Crofoot, MD, PA". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Gordon E. Crofoot, MD, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gordon E. Crofoot, MD, PA, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".